CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests…
Read MoreCND Life Sciences, Inc. (CND) announced today that it has raised $13.5 million in its…
Read MoreCND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and…
Read MoreFindings from retrospective chart review of patients with suspected Parkinson’s disease and related disorders show…
Read MoreGrant funding will support the new Syn-Q Clinical Study to further investigate the quantification of…
Read MoreCND announced the expansion of its leadership team by welcoming four new executives. Hernan Lopez…
Read MoreSynuclein-One Study plenary session on Monday, April 15 at 9:15 a.m. MT will report the…
Read MoreCND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests…
Read MoreMarch 5, 2024 – Scottsdale, Ariz – CND Life Sciences (CND), a medical technology company…
Read MoreNovember 16, 2023 – Scottsdale, Ariz. – CND Life Sciences, a medical technology company pioneering…
Read More
